4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine
Code | Size | Price |
---|
TAR-T19142-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19142-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine is a potent amyloid imaging agent that binds to Amyloid-β (1-40) (KD: 1.7 nM).
CAS:
566169-98-0
Molecular Weight:
319.22
Pathway:
Neuroscience
Purity:
0.98
SMILES:
BrC=1C=CC=2N=C(SC2C1)C3=CC=C(C=C3)NC
Target:
Beta Amyloid
References
Mathis CA, et al. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem. 2003 Jun 19;46(13):2740-54.
Klunk W, et al. Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies.